Eisai
4523.T
#2215
Rank
A$12.74 B
Marketcap
A$45.16
Share price
0.27%
Change (1 day)
3.74%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.30. an increase over its 2024 EPS that were of A$1.46.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.6311.85%
2024A$1.46-32.63%
2023A$2.175.52%
2022A$2.06-74.01%
2021A$7.91-66.58%
2020A$23.6798.24%
2019A$11.9417.01%
2018A$10.2037.78%
2017A$7.41-27.62%
2016A$10.2335.33%
2015A$7.56-2.82%
2014A$7.78-27.66%
2013A$10.76-27.49%
2012A$14.83-12.67%
2011A$16.9988.08%
2010A$9.03-11.06%
2009A$10.15-390.15%
2008A-$3.50-127.78%
2007A$12.6011.78%
2006A$11.274.38%
2005A$10.807.4%
2004A$10.0643.03%
2003A$7.0325.09%
2002A$5.6252.67%
2001A$3.6869.76%
2000A$2.17